During the past decade, Valeomed Kft conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Valeomed Kft" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "MedDay Pharmaceuticals SA" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Valeomed Kft" are "Multiple Sclerosis" (5 trials), "Migraine" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Valeomed Kft" in a lesser frequency.

Most popular intervention types in "Valeomed Kft" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (3 trials), "Mavenclad®" (2 trials), "AVP-786" (1 trials) and "Erenumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Valeomed Kft" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Valeomed Kft". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Valeomed Kft, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Valeomed Kft, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".